DDIT3 and colorectal cancer: In colorectal cancer cells, tunicamycin was found to effectively enhance TRAIL-induced apoptosis through JNK-CHOP-mediated DR5 upregulation [59], and gefitinib enhanced TRAIL-induced apoptosis by autophagy- and JNK-mediated death-receptor upregulation [64].